New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2013
08:09 EDTNEPTNeptune Technologies obtains third U.S. patent on phospholipid compositions
Neptune Technologies & Bioressources announces that the U.S. Patent & Trademark has granted to Neptune a new continuation patent, U.S. Patent 8,383,675. This new patent claims the benefit of prior Neptune U.S. Patent Nos. 8,030,348 and 8,278,351. The '675 Patent contains a single claim directed to a capsule comprising an Antarctic krill oil extract comprising a phospholipid suitable for human consumption. This claim covers most, if not all, krill oil products presently sold in the U.S. market, as well as the pharmaceutical concentrates of Neptune's subsidiaries Acasti Pharma and NeuroBioPharm. Henri Harland, president and CEO of Neptune, commented; "This is not 'just another patent for Neptune.' It is part of Neptune's IP strategy, and it reinforces Neptune's continual effort to build its patent portfolio and defend its rights. Neptune's recent filing of a complaint with the United States International Trade Commission, as well as the issuance of this third composition patent in the United States, are part of Neptune's well thought and ongoing IP action plan."
News For NEPT From The Last 14 Days
Check below for free stories on NEPT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for NEPT

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use